PE2399A1 - Vacunas de micosis - Google Patents

Vacunas de micosis

Info

Publication number
PE2399A1
PE2399A1 PE1997000879A PE00087997A PE2399A1 PE 2399 A1 PE2399 A1 PE 2399A1 PE 1997000879 A PE1997000879 A PE 1997000879A PE 00087997 A PE00087997 A PE 00087997A PE 2399 A1 PE2399 A1 PE 2399A1
Authority
PE
Peru
Prior art keywords
dsm
yeast
liquid medium
treatment
vaccines
Prior art date
Application number
PE1997000879A
Other languages
English (en)
Inventor
Igor Dimitrievich Poliakov
G Ludmilla Ivanova
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Int
Publication of PE2399A1 publication Critical patent/PE2399A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0002Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/165Yeast isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/72Candida
    • C12R2001/725Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

CARACTERIZADA PORQUE COMPRENDE MICROCONIDIOS DE DERMATOFITOS Y BLASTOESPORAS DE LEVADURAS O EL MATERIAL ANTIGENICO DE DICHAS ESPORAS, LOS CUALES SE ENCUENTRAN INACTIVADOS Y/O HOMOGENIZADOS Y AL MENOS UN 50% SE ENCUENTRA HINCHADO Y/O TIENEN TUBOS GERMINALES, EN DONDE: DICHAS BLASTOESPORAS PERTENECEN A LAS CEPAS DSM 9456 Y/O 9457 Y/O 9458 Y/O 9459 DE CANDIDA ALBICANS, Y, DICHOS MICROCONIDIOS PERTENECEN A LAS CEPAS DSM 9469 Y/O 9470 Y/O 9471 Y/O 9472 DE TRICHOPHYTON RUBRUM Y/O LA CEPA DSM 7279 DE TRICHOPHYTON MENTAGROPHYTES Y/O LA CEPA DSM 7281 DE MICROSPORUM CANIS; ESTAS ESPORAS FUNGICAS HAN SIDO INACTIVADAS CON TIOMERSAL, FORMALDEHIDO o 2-PROPIOLACTONA Y LUEGO MODIFICADOS POR TRATAMIENTO CON H2O2 O SALES DE MnO4. TAMBIEN SE REFIERE A SU PROCEDIMIENTO DE PREPARACION, QUE COMPRENDE: (A) HACER CRECER UN DERMATOFITO EN UN MEDIO SOLIDO (EXTRACTO DE MALTA O AGAR DE SABOURAUD), COSECHAR Y HOMOGENIZARLO EN UN MEDIO LIQUIDO; (B) HACER CRECER UNA LEVADURA EN UN MEDIO SOLIDO, COSECHAR, HOMOGENIZAR EN UN MEDIO LIQUIDO DE pH: 6,8-7, E INCUBAR EN UNA ATMOSFERA CON 5% A 6% DE CO2 POR 2-4 h; (C) COMBINAR E INACTIVAR LOS MATERIALES HOMOGENIZADOS DE (A) Y (B). ESTAS VACUNAS DE PREFERENCIA EN UNA CONCENTRACION DE 60 MILLONES DE ESPORAS POR ml, SON UTILES EN EL TRATAMIENTO DE MICOSIS CUTANEAS COMO DERMATOMICOSIS Y/O CANDIDIASIS Y/U ONICOMICOSIS
PE1997000879A 1996-10-04 1997-10-02 Vacunas de micosis PE2399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115954A EP0834322A3 (en) 1996-10-04 1996-10-04 Mycosis vaccine

Publications (1)

Publication Number Publication Date
PE2399A1 true PE2399A1 (es) 1999-02-10

Family

ID=8223269

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000879A PE2399A1 (es) 1996-10-04 1997-10-02 Vacunas de micosis

Country Status (17)

Country Link
US (1) US6290950B1 (es)
EP (2) EP0834322A3 (es)
JP (1) JP4698771B2 (es)
AR (1) AR008491A1 (es)
AT (1) ATE347372T1 (es)
AU (1) AU740389B2 (es)
CA (1) CA2268138C (es)
CO (1) CO4650185A1 (es)
DE (1) DE69737067T2 (es)
DK (1) DK0956042T3 (es)
ES (1) ES2279546T3 (es)
HR (1) HRP970528A2 (es)
PE (1) PE2399A1 (es)
PT (1) PT956042E (es)
RU (1) RU2219945C2 (es)
WO (1) WO1998015284A2 (es)
ZA (1) ZA978799B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
US6720576B1 (en) * 1992-09-11 2004-04-13 Semiconductor Energy Laboratory Co., Ltd. Plasma processing method and photoelectric conversion device
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
WO2001015725A1 (en) * 1998-09-24 2001-03-08 Alpharma As Vaccine for the protection of a vertebrate animal against fungal skin infection
CA2411912C (en) * 2000-06-19 2014-06-17 Candivax Pty Ltd. Compositions and methods for treatment of candidiasis
US20040043003A1 (en) * 2002-01-31 2004-03-04 Wei Chen Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
US20040009937A1 (en) * 2002-01-31 2004-01-15 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
US20050075298A1 (en) * 2002-01-31 2005-04-07 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
RU2281110C1 (ru) * 2005-02-10 2006-08-10 Владислав Николаевич Ласкавый Лекарственное средство против кандидоза человека для инъекций
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US20080220023A1 (en) * 2007-03-08 2008-09-11 Stevens David A Antifungal vaccines with saccharomyces cerevisiae
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US11173193B2 (en) 2016-03-15 2021-11-16 Igor Polyakov Immunobiological products
EP3429616B1 (en) * 2016-03-15 2021-08-04 Igor Polyakov Compositions for the treatment and prevention of hoof and claw diseases
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
CA2011896C (en) * 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
DE4007927A1 (de) * 1990-03-13 1991-09-19 Bayer Ag Pathogenese-faktoren von dermatophyten
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
CA2264496C (en) * 1996-09-04 2008-10-07 Takara Shuzo Co., Ltd. Fungal antigens and process for producing the same

Also Published As

Publication number Publication date
EP0956042A2 (en) 1999-11-17
DE69737067T2 (de) 2007-07-05
EP0834322A3 (en) 1998-04-22
EP0834322A2 (en) 1998-04-08
ZA978799B (en) 1998-04-06
CO4650185A1 (es) 1998-09-03
PT956042E (pt) 2007-04-30
AR008491A1 (es) 2000-01-19
DK0956042T3 (da) 2007-04-10
EP0956042B1 (en) 2006-12-06
JP4698771B2 (ja) 2011-06-08
WO1998015284A3 (en) 1999-09-23
AU4460497A (en) 1998-05-05
CA2268138A1 (en) 1998-04-16
US6290950B1 (en) 2001-09-18
ES2279546T3 (es) 2007-08-16
RU2219945C2 (ru) 2003-12-27
HRP970528A2 (en) 1998-08-31
CA2268138C (en) 2009-01-06
DE69737067D1 (de) 2007-01-18
ATE347372T1 (de) 2006-12-15
AU740389B2 (en) 2001-11-01
JP2001503975A (ja) 2001-03-27
WO1998015284A2 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
PE2399A1 (es) Vacunas de micosis
Pitt et al. Pathogenicity and epidemiology of Botryosphaeriaceae species isolated from grapevines in Australia
Billones-Baaijens et al. A review of Botryosphaeriaceae species associated with grapevine trunk diseases in Australia and New Zealand
Veloukas et al. Fitness and competitive ability of Botrytis cinerea field isolates with dual resistance to SDHI and QoI fungicides, associated with several sdh B and the cyt b G143A mutations
Yao et al. Effects of a biocontrol agent and methyl jasmonate on postharvest diseases of peach fruit and the possible mechanisms involved
Konstantinou et al. Population structure, fungicide resistance profile, and sdhB mutation frequency of Botrytis cinerea from strawberry and greenhouse-grown tomato in Greece
Luque et al. Pathogenicity of fungi isolated from Quercus suber in Catalonia (NE Spain)
Kunova et al. Metrafenone resistance in a population of Erysiphe necator in northern Italy
Cotoras et al. Farnesol induces apoptosis-like phenotype in the phytopathogenic fungus Botrytis cinerea
Acheampong et al. Temperature tolerance and humidity requirements of select entomopathogenic fungal isolates for future use in citrus IPM programmes
Dugan et al. Incidence, aggressiveness and in planta interactions of Botrytis cinerea and other filamentous fungi quiescent in grape berries and dormant buds in Central Washington State
Li et al. Alternaria tenuissima causing leaf spot and fruit rot on pepper (Capsicum annuum): first report in China
Sosnowski et al. The influence of water deficit stress on the grapevine trunk disease pathogens Eutypa lata and Diplodia seriata
Nusaibah et al. Antagonistic efficacy of Trichoderma harzianum and Bacillus cereus against Ganoderma disease of oil palm via dip, place and drench (DPD) artificial inoculation technique
Schmitz et al. First report of Neonectria neomacrospora on Abies grandis in Belgium
Yin et al. The natural fenhexamid‐resistant grey mould populations from strawberry in Zhejiang Province are dominated by Botrytis cinerea group S
Fischer et al. Impact of Quillaja saponaria saponins on grapevine ecosystem organisms
Rueda‐Hernández et al. Differential organ distribution, pathogenicity and benomyl sensitivity of Colletotrichum spp. from blackberry plants in Northern Colombia
Karkee et al. Efficacy of fungicides against Rhizoctonia solani inciting rhizome rot diseases on large cardamom (Amomum subulatum Roxb.)
Pathan et al. The puzzle of highly virulent Metarhizium anisopliae strains from Annona squamosa fields against Helicoverpa armigera
Travadon et al. Field evaluation of biological wound treatments for the management of almond, cherry, and grapevine fungal canker diseases
Tongon et al. Fungal metabolites from Chaetomium brasiliense to inhibit Fusarium solani
Banerjee et al. First report of leaf blight and twig dieback caused by Mycoleptodiscus indicus on Ixora coccinea
Golmohammadi et al. Neofusicoccum parvum associated with pomegranate branch canker in Iran
Martinez et al. Ultrastructure of the infection process of potato tuber by Helminthosporium solani, causal agent of potato silver scurf

Legal Events

Date Code Title Description
FD Application declared void or lapsed